TL;DR

Key Facts

What Are They?

The oral cavity and surrounding region contain an elaborate system of salivary glands — three pairs of major glands (parotid, submandibular, sublingual) and hundreds of minor salivary glands distributed throughout the oral mucosa (particularly the palate, lips, buccal mucosa, and floor of the mouth). Disease processes affecting these glands range from simple obstructive or inflammatory conditions to complex benign neoplasms and aggressive malignancies.

The oral cavity and oropharynx are also rich in lymphoid tissue — the Waldeyer ring (palatine tonsils, pharyngeal tonsil/adenoids, lingual tonsil, tubal tonsils) forms a sentinel ring of lymphoid tissue guarding the upper aerodigestive tract. Lymph nodes are abundant in the perioral and cervical regions, and the oral mucosa contains scattered mucosal-associated lymphoid tissue (MALT). Lymphoid lesions of the oral region include reactive lymphadenopathy (by far the most common), MALT lymphoma, and other non-Hodgkin lymphomas.

Together, salivary and lymphoid lesions represent a clinically important group because many present as innocuous-seeming swellings in the oral, perioral, or neck region that may be malignant or may be markers of serious systemic disease.

Why It Matters (Clinical + Exam Context)

Salivary and lymphoid lesions are clinically important for several reasons: they are common, they can mimic other conditions, and several carry significant malignant potential or indicate systemic disease requiring prompt investigation and referral.

Clinical Relevance

• Parotid masses and facial nerve: The facial nerve (CN VII) passes through the parotid gland, dividing it into superficial and deep lobes. Malignant parotid tumours may invade the facial nerve, causing facial palsy. The new onset of facial weakness in a patient with a parotid mass is a red flag for malignancy requiring urgent specialist referral.
• Rule of 80s for parotid tumours: Approximately 80% of all salivary gland tumours occur in the parotid; of these, 80% are benign; of the benign tumours, 80% are pleomorphic adenomas. For the submandibular gland, the ratio is roughly 50% benign; for the sublingual and minor salivary glands, the majority of tumours are malignant — any minor salivary gland tumour on the palate must be considered malignant until proven otherwise.
• Sjögren syndrome and lymphoma risk: Patients with primary Sjögren syndrome have a 44-fold increased risk of developing B-cell MALT lymphoma. Any Sjögren patient with rapidly enlarging salivary glands, lymphadenopathy, or constitutional symptoms must be investigated urgently for lymphoma.
• Sialolithiasis and meal-time swelling: The classic presentation of submandibular sialolithiasis is painful submandibular swelling provoked by eating (anticipation of eating increases salivary flow, causing saliva to back up behind the calculus). Many patients have experienced this for years before seeking dental care, illustrating the importance of history-taking that includes questions about meal-time swelling.

Reactive Salivary Lesions

Mucocele

The mucocele is the most common salivary gland lesion. It results from disruption of a minor salivary gland duct, typically by trauma (lip biting), causing mucin to extravasate into the surrounding connective tissue (mucous extravasation cyst — the most common type) or to accumulate in a dilated, obstructed duct (mucous retention cyst — less common, lacks epithelial lining). Clinically it presents as a fluctuant, dome-shaped, bluish-translucent swelling on the lower lip mucosa (>90% of cases), though it can also occur on the buccal mucosa, ventral tongue, or floor of mouth. Mucoceles range from a few millimetres to over 1 cm. They may rupture spontaneously, releasing mucin and appearing to resolve, but then recur. Treatment is surgical excision of the lesion together with the involved minor salivary gland lobule to prevent recurrence. The ranula is a special form of mucocele arising from the sublingual gland, presenting in the floor of the mouth (see Red and Blue Lesions article).

Sialolithiasis (Salivary Gland Calculi)

Sialolithiasis is the formation of calcified concretions (sialoliths) within the salivary duct or gland parenchyma. The submandibular gland accounts for approximately 80–85% of sialoliths, due to its thick, viscous, calcium-rich saliva, the long upward course of Wharton’s duct, and the dependent position of the duct. Calculi may be palpable bimanually in the floor of the mouth, and small sialoliths can often be identified on occlusal or periapical radiographs (approximately 80–90% are radiopaque). The classic presentation is postprandial submandibular swelling and pain — salivary flow increases at mealtimes but is obstructed, causing gland engorgement. Chronic or recurrent sialolithiasis can lead to ascending sialadenitis and gland scarring. Small accessible calculi can be removed intraorally; larger or deeply placed calculi may require gland excision.

Sialadenitis

Acute bacterial sialadenitis presents as a sudden-onset, painful, tender unilateral swelling of a major salivary gland with overlying erythema and fever. Purulent discharge can often be expressed from the duct orifice. It most commonly affects the parotid gland in debilitated, dehydrated, or post-surgical patients where salivary flow is reduced. The causative organism is most often Staphylococcus aureus. Treatment is with systemic antibiotics (penicillin/flucloxacillin), adequate hydration, gland massage, and sialogogues (sour sweets to stimulate flow). Chronic sialadenitis often follows recurrent acute episodes or sialolithiasis and may progress to gland destruction requiring excision.

Sjögren Syndrome

Sjögren syndrome is a systemic autoimmune disease characterised by lymphocytic infiltration and destruction of the exocrine glands, primarily the salivary and lacrimal glands. It presents with the classic triad of xerostomia (dry mouth), xerophthalmia (dry eyes), and bilateral non-tender parotid gland enlargement. Primary Sjögren syndrome occurs alone; secondary Sjögren syndrome occurs in conjunction with another autoimmune disease (most commonly rheumatoid arthritis, SLE, or scleroderma). Diagnosis is based on clinical criteria, serology (anti-Ro/SSA and anti-La/SSB antibodies, rheumatoid factor, ANA), minor salivary gland biopsy (showing lymphocytic foci — a focus score ≥1 per 4 mm² is diagnostic), and Schirmer test (measuring lacrimal secretion). Dental implications include rampant cervical caries due to hyposalivation, candidal infections, and dysphagia. The dramatically increased lymphoma risk mandates long-term surveillance.

Salivary Gland Tumours

The salivary glands give rise to a diverse group of tumours reflecting their complex cellular composition — ductal epithelium, myoepithelial cells, mucous cells, and serous acinar cells all contribute to various tumour subtypes. Understanding the “rule of 80s” provides a useful clinical framework.

Pleomorphic Adenoma — The Critical Points

The pleomorphic adenoma deserves special attention for several reasons. First, it is the most common salivary gland tumour overall, accounting for approximately 60–70% of all salivary gland neoplasms. Second, its treatment — superficial or total parotidectomy with facial nerve preservation — requires considerable surgical skill, as the pseudopod extensions that project through the thin, incomplete capsule must be removed with adequate margins to prevent the high recurrence rates (up to 25%) seen after simple enucleation. Third, after 10–15 years, approximately 6–10% of untreated or inadequately excised pleomorphic adenomas undergo malignant transformation to carcinoma ex pleomorphic adenoma — one of the most aggressive salivary malignancies. Any rapidly growing or painful nodule within a long-standing parotid mass must be biopsied urgently.

Adenoid Cystic Carcinoma — Perineural Invasion

Adenoid cystic carcinoma (ACC) is perhaps the most instructive malignant salivary tumour from a clinical perspective. Its hallmark is relentless perineural invasion — the tumour tracks along nerve sheaths over long distances, sometimes far beyond the clinically apparent tumour margin. In the parotid, this may cause facial neuralgia or paresis. In minor salivary gland tumours of the palate, the tumour may track along the greater palatine nerve through the pterygoid plates and into the base of skull. Microscopy reveals the classic cribriform pattern — islands of small dark cells arranged around cylindrical spaces (“holes”) filled with basement membrane-like material, creating a “Swiss cheese” appearance. The prognosis is deceptive: early-stage disease appears controllable, but late local recurrence and distant lung metastases (occurring 10–20 years after primary treatment) make the long-term prognosis poor for most patients.

Lymphoid Lesions

Reactive Lymphadenopathy

The vast majority of enlarged cervical and submandibular lymph nodes encountered in dental practice represent reactive lymphadenopathy — non-specific enlargement in response to local infection or inflammation (carious teeth, periodontal disease, oral ulcers, periapical abscess). Reactive nodes are typically tender, mobile, soft to firm, and enlarge acutely. They resolve within 2–4 weeks once the causative infection is treated. Persistent, firm, non-tender, matted, or rapidly enlarging lymphadenopathy lasting more than 3 weeks without an obvious cause must be investigated for lymphoma, metastatic carcinoma, or granulomatous disease (tuberculosis, sarcoidosis).

Oral Tonsil and Waldeyer Ring Lesions

The palatine tonsils are a frequent site of reactive hyperplasia (tonsillitis), crypt-related retention cysts (tonsilloliths), and — importantly — primary malignancy. Squamous cell carcinoma of the tonsil is the most common oropharyngeal cancer; many are HPV-related (particularly HPV 16) and occur in younger, non-smoking patients. Tonsil lymphomas (most often diffuse large B-cell lymphoma) present as rapidly enlarging, asymmetric tonsillar swellings. Any unilateral tonsillar asymmetry in an adult without a history of acute infection requires evaluation for malignancy.

Non-Hodgkin Lymphoma (NHL) of the Oral Region

Primary oral NHL most commonly presents as a diffuse, non-tender, firm-to-rubbery swelling of the soft palate, tonsillar region, or gingiva. The overlying mucosa may be intact or ulcerated. The most common subtypes in the oral region are diffuse large B-cell lymphoma (DLBCL) and extranodal marginal zone lymphoma (MALT lymphoma). MALT lymphoma of the salivary glands is particularly associated with Sjögren syndrome — the chronic lymphocytic infiltration of the gland provides fertile ground for clonal B-cell expansion. Constitutional (“B”) symptoms — fever, night sweats, weight loss — may accompany high-grade lymphoma but are absent in low-grade disease. Any unexplained firm oral swelling must be biopsied; lymphoma cannot be reliably diagnosed without histopathology and immunophenotyping.

Hodgkin Lymphoma and Cervical Nodes

Although Hodgkin lymphoma does not typically present intraorally, cervical lymphadenopathy is the most common presenting feature in young adults with Hodgkin lymphoma. The affected nodes are characteristically enlarged, firm, non-tender, and described as having a “rubbery” texture. They may be discovered by the patient or incidentally by the dentist during head and neck examination. Reed-Sternberg cells on biopsy are pathognomonic of classical Hodgkin lymphoma. The dentist who identifies unexplained cervical lymphadenopathy and refers promptly may be the first clinician to trigger a potentially curative diagnosis.

Clinical Considerations

• Bimanual palpation for salivary calculi: For suspected submandibular sialolithiasis, bimanual palpation (one finger intraorally in the floor of the mouth, one extraorally beneath the jaw) allows assessment of the gland and Wharton’s duct along its entire course. A calculus may be palpable as a firm, non-mobile, often tender nodule within the duct.
• FNAC for salivary masses: Fine-needle aspiration cytology (FNAC) is the standard first-line investigation for any salivary gland mass. It is minimally invasive, rapid, and provides cytological information that guides surgical planning. Sensitivity is approximately 85–95% for malignancy. Open biopsy of a parotid mass is contraindicated in primary assessment because of the risk to the facial nerve and the possibility of tumour cell spillage.
• Imaging: Ultrasound is the first-line imaging modality for salivary gland masses and can identify sialoliths, cystic vs. solid lesions, and lymph node characteristics. MRI provides superior soft tissue characterisation and nerve involvement assessment. CT with contrast is used for staging of malignant tumours. Sialography (contrast injection into the duct) is reserved for assessment of duct strictures and chronic sialadenitis.
• Minor salivary gland tumours on the palate: Any firm, non-fluctuant, slow-growing palatal swelling should be considered a salivary gland tumour until proven otherwise. Fluctuant, bluish swellings may be retention cysts. The majority of minor salivary gland tumours are malignant (in contrast to parotid tumours). Biopsy is essential; incisional biopsy of the mucosa overlying the lesion is the standard approach.
• Xerostomia management in Sjögren patients: Regular recall (3–4 monthly), fluoride supplementation, antifungal prophylaxis, saliva substitutes, and systemic sialogogue therapy (pilocarpine, cevimeline) form the cornerstone of dental management for patients with Sjögren syndrome-related xerostomia.

Common Mistakes & Misconceptions

• Misconception: “A mucocele on the lower lip should be observed — it will resolve on its own.”
  Correction: While mucoceles may rupture and temporarily appear to resolve, they nearly always recur unless the involved minor salivary gland lobule is surgically excised along with the cyst contents. Observation alone leads to repeated rupture and recurrence, and carries the small risk of a missed diagnosis.
• Misconception: “Bilateral parotid enlargement is always Sjögren syndrome.”
  Correction: Bilateral parotid enlargement (parotid hypertrophy) has multiple causes: Sjögren syndrome, alcoholic liver disease, diabetes, malnutrition/bulimia, and HIV-associated parotid disease. A systematic clinical and serological workup is required before attributing bilateral parotid enlargement to any single cause.
• Misconception: “The submandibular gland is the most common site for salivary tumours.”
  Correction: The parotid gland is the most common site for salivary gland tumours (~80% of all salivary tumours). The submandibular gland accounts for approximately 10%, and minor salivary glands for approximately 10%. However, the proportion of malignant tumours increases as gland size decreases.
• Misconception: “Pleomorphic adenoma is cured by simple enucleation.”
  Correction: Simple enucleation of a pleomorphic adenoma carries a high recurrence rate (up to 25%) because pseudopod tumour extensions penetrate through the incomplete capsule into the surrounding parenchyma. The standard of care is superficial parotidectomy with an adequate margin of normal tissue around the tumour.

Related Topics

References & Sources

1. Neville BW, Damm DD, Allen CM, Chi AC. (2016). Oral and Maxillofacial Pathology, 4th ed. Elsevier.
2. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds.). (2017). WHO Classification of Head and Neck Tumours, 4th ed. IARC Press.
3. Regezi JA, Sciubba JJ, Jordan RCK. (2017). Oral Pathology: Clinical Pathologic Correlations, 7th ed. Elsevier.
4. Vitali C, Bombardieri S, Jonsson R, et al. (2002). Classification criteria for Sjögren’s syndrome. Annals of the Rheumatic Diseases, 61(6), 554–558.
5. Odell EW (Ed.). (2017). Cawson’s Essentials of Oral Pathology and Oral Medicine, 9th ed. Elsevier.

Summary

Salivary and lymphoid lesions of the oral and perioral region encompass a broad spectrum — from the common and easily managed mucocele and salivary calculus to the diagnostically challenging salivary gland carcinoma and life-threatening lymphoma. The dental clinician’s role in this group of conditions extends beyond simple recognition to include systematic history-taking (meal-time swelling, dry eyes, dry mouth, constitutional symptoms), appropriate investigations (FNAC, imaging, serological screening), and prompt referral when malignancy or serious systemic disease is suspected.

About the Author

Dr. Andries Smith

Founder, Dental Panda

Dr. Andries Smith founded Dental Panda in 2020. As an immigrant to the United States, he had to take the INBDE exam, even though he was practicing dentistry for over 10 years. This revealed an opportunity. Andries noticed that INBDE prep course companies were putting profit over students. With his expertise and experience in dentistry, he created free dental wiki resources for students and the general public to have access to.